Detalhe da pesquisa
1.
Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy.
BMC Med
; 20(1): 369, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280874
2.
Ibrutinib combined with low-dose histone deacetylases inhibitor chidamide synergistically enhances the anti-tumor effect in B-cell lymphoma.
Hematol Oncol
; 40(5): 894-905, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975476
3.
Anti-CD47 immunotherapy in combination with BCL-2 inhibitor to enhance anti-tumor activity in B-cell lymphoma.
Hematol Oncol
; 40(4): 596-608, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477179
4.
Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma.
Ann Hematol
; 101(9): 2021-2034, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798977
5.
Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China.
Front Oncol
; 13: 1264723, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941553
6.
Water-assisted and protein-initiated fast and controlled ring-opening polymerization of proline N-carboxyanhydride.
Natl Sci Rev
; 9(8): nwac033, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36072505
7.
Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen.
Aging (Albany NY)
; 14(7): 3203-3215, 2022 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35400665
8.
Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma.
Mol Ther Oncolytics
; 21: 158-170, 2021 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33981831
9.
An urchin-like helical polypeptide-asparaginase conjugate with mitigated immunogenicity.
Biomaterials
; 268: 120606, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33360506
10.
The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma.
Cancers (Basel)
; 13(17)2021 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503063